In a study by Cipriano et al., the intra-amygdalar administration of CRH resulted in a reduction in open arm time and entries in the EPM test, while a selective CRHR1 antagonist induced an anxiety-like effect, pointing to the involvement of amygdalar CRHR1 signaling in anxiety [17]. The gene discussed is CRH; the disease is Anxiety.